Hisamitsu Pharmaceutical Company Inc Unsponsored ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $7.36
- Today's High:
- $7.64
- Open Price:
- $7.36
- 52W Low:
- $6.56
- 52W High:
- $7.64
- Prev. Close:
- $7.56
- Volume:
- 500
Company Statistics
- Market Cap.:
- $0
- Book Value:
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $92.77 billion
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR had its IPO on under the ticker symbol HTSUY.
The company operates in the Other sector and Other industry. Hisamitsu Pharmaceutical Company Inc Unsponsored ADR has a staff strength of 2,751 employees.
Stock update
Shares of Hisamitsu Pharmaceutical Company Inc Unsponsored ADR opened at $7.36 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $7.36 - $7.64, and closed at $7.64.
This is a +1.06% increase from the previous day's closing price.
A total volume of 500 shares were traded at the close of the day’s session.
In the last one week, shares of Hisamitsu Pharmaceutical Company Inc Unsponsored ADR have increased by +3.52%.
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR's Key Ratios
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Hisamitsu Pharmaceutical Company Inc Unsponsored ADR’s revenue was $0 with a gross profit of $92.77 billion and an EBITDA of $0. The EBITDA ratio measures Hisamitsu Pharmaceutical Company Inc Unsponsored ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Hisamitsu Pharmaceutical Company Inc Unsponsored ADR’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q3.6666666666667, Hisamitsu Pharmaceutical Company Inc Unsponsored ADR’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Hisamitsu Pharmaceutical Company Inc Unsponsored ADR’s profitability.
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $298.76 billion
- Total Liabilities
- $37.40 billion
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR ended 2024 with $298.76 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $298.76 billion while shareholder equity stood at $240.41 billion.
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR ended 2024 with $0 in deferred long-term liabilities, $37.40 billion in other current liabilities, 8473000000.00 in common stock, $233.19 billion in retained earnings and $0 in goodwill. Its cash balance stood at $90.45 billion and cash and short-term investments were $0. The company’s total short-term debt was $2,010,000,000 while long-term debt stood at $524.00 million.
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR’s total current assets stands at $187.95 billion while long-term investments were $64.78 billion and short-term investments were $35.51 billion. Its net receivables were $34.00 billion compared to accounts payable of $14.50 billion and inventory worth $17.40 billion.
In 2024, Hisamitsu Pharmaceutical Company Inc Unsponsored ADR's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Hisamitsu Pharmaceutical Company Inc Unsponsored ADR paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $7.64
- 52-Week High
- $7.64
- 52-Week Low
- $6.56
- Analyst Target Price
- $
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR stock is currently trading at $7.64 per share. It touched a 52-week high of $7.64 and a 52-week low of $7.64. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $8.45 and 200-day moving average was $9.82 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Hisamitsu Pharmaceutical Company Inc Unsponsored ADR
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals. It offers SALONPAS pain relief products in the form of patches, sprays, gels, creams, liniments, and lotions; SALONSIP gel patches and heat pads; ByeBye-FEVER, a cooling gel sheet for fever discomfort in babies, children, and adults; Lifecella facial and gel sheet masks; and MOHRUS and KEPLAT pain relieving patches. The company sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.